活血消癥中药治疗糖尿病肾病的随机对照临床试验系统综述及Meta分析
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

北京市“十病十方”科技攻关项目;国家中医临床研究基地重点病种专项研究


Randomized Controlled Clinical Trial of Blood-activating and Stasis-resolving Herbs in Treatment of DN:A Systematic Review and Meta-Analysis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨活血消癥中药辨证治疗糖尿病肾病(Diabetic Nephropathy,DN)的有效性及安全性。方法:检索5个主要的电子数据库(中文数据库:中国知网(CNKI)、万方、维普(VIP),英文数据库:Medline、CENTRAL),检索日期从建库至2016年7月。筛选纳入并Meta分析活血消癥中药治疗DN的随机对照试验(Randomized Controlled Trials,RCT)。结果:活血消癥中药对于改善患者24 h尿蛋白定量(quantitative test of 24 h urinary protein,24 hUTP)(MD=-0.08 g,95%CI=[-0.13,-0.03],I2=0%)和中医证候积分(MD=-3.82,95%CI=[-4.84,-2.79],I2=0%)疗效优于ACEI/ARB类药物。对于SCr和BUN的影响,组间差异无统计学意义。结论:活血消癥中药降低DN患者24 hUTP和改善临床症状疗效优于ACEI/ARB类药物。

    Abstract:

    To explore the efficacy and safety of blood-activating and stasis-resolving herbs in treatment of diabetic nephropathy (DN).Methods:A total of 5 major electronic databases were retrieved.Chinese databases include:CNKI,Wan Fang database,VIP database,English databases include:Medline,CENTRAL.Retrieve the date from inception date to July 2016.Meta-Analysis was used to analyze the randomized controlled trials (RCTs) in Chinese herbal medicine therapy for DN.Results:Blood-activating and stasis-resolving herbs is better than ACEI/ARB in improving 24 hUTP (MD=-0.08 g,95%CI=[-0.13,-0.03],I2=0%)and TCM syndrome scores (MD=-3.82,95%CI=[-4.84,-2.79],I2=0%).For the effects of SCr and BUN,there were no significant differences between the groups.Conclusion:Blood-activating and stasis-resolving herbs to reduce DN patients′ 24 hUTP and improve clinical symptoms is better than ACEI/ARB.

    参考文献
    相似文献
    引证文献
引用本文

杨涛,李潇然,王世东,肖永华,赵进喜,倪博然,陈默,吕仁和,李佳玥,韩媛媛,李彤.活血消癥中药治疗糖尿病肾病的随机对照临床试验系统综述及Meta分析[J].世界中医药,2017,(01).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-12-20
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-03-16
  • 出版日期:
文章二维码